Neutron capture therapy for infection control of surgical implants

Patent metadata

Field	Value
Publication number	US-12397173-B2
Application number	US-201716349445-A
Country	US
Kind code	B2
Filing date	Nov 14, 2017
Priority date	Nov 14, 2016
Publication date	Aug 26, 2025
Grant date	Aug 26, 2025

Abstract

The present invention provides an implant comprising an isotope capable of producing a dose of ionizing radiation upon exposure to a flux of low energy neutrons, and a method in which, after implantation, the implant is exposed to a flux of low energy neutrons to control or treat infections.

First claim

We claim:

1. A method for treating infection at an implantation site comprising: implanting a device comprising an isotope capable of producing a dose of ionizing radiation upon exposure to a flux of low energy neutrons into an human or animal subject, wherein the device is not a stent; and exposing said device to a flux of low energy neutrons to produce a dose of ionizing radiation suitable for treating bacterial infection at said implantation site; wherein the device comprises a body made of a material having a low neutron absorption cross-section and a surface layer of 1 μm to 100 μm thickness on the body, the isotope is selected from the group consisting of B-10, Li-6, Gd-157 and Dy-164 being disposed in the surface layer, such that the isotope is present at the surface of the device upon implantation.

2. The method of claim 1 , wherein said dose of ionizing radiation within 6 μm of a surface of said device is greater than 2 kGy.

3. The method of claim 1 , wherein the thermal neutron fluence delivered in said exposing step is greater than 7.5×10 11 n/cm 2 .

4. The method of claim 1 , wherein said device is exposed to said flux of low energy neutrons for five minutes to 30 minutes.

5. The method of claim 1 , wherein the flux of low energy neutrons is 0.001 eV to 100 keV, 0.001 eV to 0.5 eV, 0.5 eV to 100 keV, 0.5 eV to 100 eV, or 100 eV to 100 keV.

6. The method of claim 1 , wherein said flux of low energy neutrons produced at the implantation site during said exposing step is 1×10 8 to 15×10 8 neutrons cm −2 s −1 .

7. The method of claim 1 , wherein a survival fraction of bacteria at said implantation site after said exposing step is 0.62×10 5 to 3.1×10 5 compared to a non-irradiated control.

8. The method of claim 1 , wherein 0.3% or fewer of the bacterial infection at said implantation site survive said exposing step.

9. The method of claim 1 , wherein said dose of ionizing radiation within 6 μm of a surface of said device is greater than 10 kGy, and said exposure is less than 30 minutes.

10. The method of claim 1 , wherein said dose of ionizing radiation within 6 μm of a surface of said device is greater than 10 kGy, and a background dose delivered within said 6 μm is less than 100 cGy.

11. The method of claim 1 , wherein said exposing step is performed in response to an indication of infection at said implantation site.

12. The method of claim 1 , wherein said exposing step is repeated in response to a subsequent indication of infection at said implantation site.

13. The method of claim 1 , wherein said device is implanted at a depth of less than 2 cm and said flux of low energy neutrons is 0.0001 eV to 0.5 eV.

14. The method of claim 1 , wherein said device is implanted at a depth of greater than 1 cm and said flux of low energy neutrons is 0.5 eV to 10 keV.

15. The method of claim 1 , wherein said device is an orthopedic implant.

16. The method of claim 1 , wherein the body is made primarily of titanium.

17. The method of claim 1 , wherein the isotope is anti-infective only after being exposed to the flux of low energy neutrons.

18. The method of claim 1 , wherein the material comprises 30% or greater of the isotope, 50% or greater of the isotope, or 90% or greater of the isotope.

Assignees

• Univ Missouri

Inventors

• Gahl John
• Brockman John
• Flagg Michael
• Volgas David A
• Stannard James
• Maitz Charles

Classifications

• A61K41/009

  Neutron capture therapy, e.g. using uranium or non-boron material · CPC title

• A61L27/50

  Materials characterised by their function or physical properties {, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials} · CPC title

• A61L31/16

  Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)} · CPC title

• G21G4/08

  specially adapted for medical application (radiation therapy using radioactive sources A61N5/10) · CPC title

• A61N2005/109

  Neutrons · CPC title